Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has acquired the 68.0% of the shares in Swiss pharmaceutical company Osmopharm and has disinvested the 76.4% in Egyptian pharmaceutical manufacturer SPIMACO Misr for Pharmaceutical Industries. The Transaction, with a total value of SAR 16.1 million, involves a share swap supplemented with a cash consideration, and is […]
Partners Group, a renowned global private markets firm, acting on behalf of its clients, has agreed to acquire ROSEN Group, a global provider of mission-critical inspection services for energy infrastructure assets, from its founder, Hermann
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has announced the completion of its oversubscribed Series C equity financing raising €67.5 million ($72 million) from a syndicate of renowned
Solar Impulse Foundation launches RUNWAY, a new matchmaking tool for cleantech that allows to direct capital towards clean and efficient ventures to create an economy evolving within planetary boundaries. The platform will be live on 28
Nanogence closed its Series A financing round, securing financing from a consortium of investors. The consortium was led by CirCap, an investment platform providing strategic private capital to innovative companies in climate-tech, healthcare and education,
Baker McKenzie Switzerland advised Arab Bank Switzerland on its acquisition of the Quarz’Up project, a first-class, multifunctional commercial development project in Vernier near Geneva in a share deal. The Quarz’Up project will be
Competition & Antitrust
Corporate
Lenz & Staehelin: Vencora announces PTO for Crealogix publicly held
Vencora and CREALOGIX, a global player in digital banking technology, jointly announced today that they have entered into a definitive transaction agreement, under which Vencora agreed to submit an all-cash public tender offer to acquire
Memo Therapeutics, a late-stage biotech company developing best-in-class therapeutic antibodies closed a CHF 25 million series C financing round led by Pureos Bioventures. Existing investors Swisscanto, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, Schroders Capital, GF Group,
B+G Schweiz, a renowned Swiss gardening and landscaping group and portfolio company of Patrimonium Private Equity and EGS Beteiligungen, has acquired a
Alcon, a renowned eye care product company, in its capacity as borrower and guarantor entered into a USD 1.32 bn revolving credit facilities agreement with, among others, Citibank, London Branch, BNP PARIBAS (SUISSE), Bank of America
